Article
Lipids, lipid-modifying drug Target genes and Bladder cancer: a Mendelian randomization study
2023-11-07
Abstract excerpt
<h4>Background: </h4> Bladder cancer (BLCA) is among the 10th most common malignancies with high morbidity and mortality. Statins and emerging lipid-modifying drug targets may also show potential in treating BLCA and lowering cholesterol levels. Mendelian randomization (MR) analysis provides insights into the causal relationship between exposure and disease. This study aimed to explore genetically predicted lipid...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- ae1a80f6-04a1-5077-ba09-d0aa1955f657
- DOI
- 10.21203/rs.3.rs-3541205/v1
